SG11201907911PA - Process for crystallizing 2'-fucosyllactose and related compositions - Google Patents

Process for crystallizing 2'-fucosyllactose and related compositions

Info

Publication number
SG11201907911PA
SG11201907911PA SG11201907911PA SG11201907911PA SG11201907911PA SG 11201907911P A SG11201907911P A SG 11201907911PA SG 11201907911P A SG11201907911P A SG 11201907911PA SG 11201907911P A SG11201907911P A SG 11201907911PA SG 11201907911P A SG11201907911P A SG 11201907911PA
Authority
SG
Singapore
Prior art keywords
international
pct
fucosyllactose
crystallizing
plaza
Prior art date
Application number
SG11201907911PA
Other languages
English (en)
Inventor
Juha Nurmi
Pentti Backman
Heidi Martikainen
Jani Siitonen
Original Assignee
Dupont Nutrition Biosci Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dupont Nutrition Biosci Aps filed Critical Dupont Nutrition Biosci Aps
Priority claimed from PCT/US2018/020431 external-priority patent/WO2018164937A1/en
Publication of SG11201907911PA publication Critical patent/SG11201907911PA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Pediatric Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Confectionery (AREA)
SG11201907911PA 2017-03-06 2018-03-01 Process for crystallizing 2'-fucosyllactose and related compositions SG11201907911PA (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762467571P 2017-03-06 2017-03-06
EP17167564 2017-04-21
US201862632180P 2018-02-19 2018-02-19
PCT/US2018/020431 WO2018164937A1 (en) 2017-03-06 2018-03-01 Process for crystallizing 2'-fucosyllactose and related compositions

Publications (1)

Publication Number Publication Date
SG11201907911PA true SG11201907911PA (en) 2019-09-27

Family

ID=67844871

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201907911PA SG11201907911PA (en) 2017-03-06 2018-03-01 Process for crystallizing 2'-fucosyllactose and related compositions

Country Status (7)

Country Link
EP (1) EP3596095A4 (ko)
JP (1) JP2020509073A (ko)
KR (1) KR20190126350A (ko)
CN (1) CN110621685A (ko)
AU (1) AU2018230564A1 (ko)
BR (1) BR112019018410A2 (ko)
SG (1) SG11201907911PA (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116847854A (zh) 2020-12-11 2023-10-03 高级蛋白质技术公司 包含岩藻糖基乳糖作为有效成分的抗病毒组合物
CN113004347B (zh) * 2021-02-19 2022-12-23 中国科学院合肥物质科学研究院 一种分离和纯化2’-岩藻糖基乳糖的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8406734D0 (en) * 1984-03-15 1984-04-18 Tate & Lyle Plc Sugar process
AU2003253460A1 (en) * 2002-09-19 2004-04-08 Cj Corporation Crystalline organic acid salt of amlodipine
CA2798675A1 (en) * 2010-06-01 2011-12-08 Glycom A/S Polymorphs of 2'-o-fucosyllactose and producing thereof
EP2861609A4 (en) * 2012-06-14 2015-11-04 Glycom As IMPROVING STABILITY AND PURITY AND INCREASING THE BIOAVAILABILITY OF HUMAN MILK OLIGOSACCHARIDES OR PRECURSORS OR MIXTURES THEREOF
ITFI20120143A1 (it) * 2012-07-12 2014-01-13 Inalco S A S Di Giovanni Cipollett I & C Polimorfi idrati e anidri del 2'-o-fucosillattosio e loro metodi di produzione.
US11160817B2 (en) * 2012-12-18 2021-11-02 Abbott Laboratories Nutritional compositions comprising neuroprotective dietary oligosaccharides
ES2933616T3 (es) * 2014-12-16 2023-02-10 Glycom As Separación de 2'-FL de un caldo de fermentación

Also Published As

Publication number Publication date
KR20190126350A (ko) 2019-11-11
BR112019018410A2 (pt) 2020-04-07
CN110621685A (zh) 2019-12-27
EP3596095A4 (en) 2021-01-27
EP3596095A1 (en) 2020-01-22
JP2020509073A (ja) 2020-03-26
AU2018230564A1 (en) 2019-09-12

Similar Documents

Publication Publication Date Title
SG11201909868YA (en) Compositions and methods of treating huntington's disease
SG11201908813QA (en) Anti-sirp alpha antibodies
SG11201810600WA (en) Fxr (nr1h4) modulating compounds
SG11201906763RA (en) Pyrrolo [1,2-b] pyridazine derivatives
SG11201811431VA (en) Multispecific antibodies against cd40 and cd137
SG11201407774XA (en) Conversion of biomass
SG11201803933PA (en) Optical metrology of lithographic processes using asymmetric sub-resolution features to enhance measurement
SG11201805950UA (en) Self-assembled nanostructures and separation membranes comprising aquaporin water channels and methods of making and using them
SG11201809830WA (en) Selective reduction of cysteine-engineered antibodies
SG11201807827VA (en) Process for the preparation of pegylated drug-linkers and intermediates thereof
SG11201909011PA (en) Niraparib compositions
SG11201908640TA (en) Pyrrolidinones and a process to prepare them
SG11201808476SA (en) Recycling of polymer matrix composite
SG11201908325PA (en) Process for the preparation of glucuronide drug-linkers and intermediates thereof
SG11201803918VA (en) Production of steviol glycosides in recombinant hosts
SG11201809908TA (en) Stabilized glycopeptide antibiotic formulations
SG11201808686VA (en) Synthesis of indazoles
SG11201808108XA (en) Synthesis of indazoles
SG11201810177VA (en) Pet-imaging immunomodulators
SG11201408251SA (en) A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota
SG11201907434RA (en) Compositions and methods for immunooncology
SG11202000333UA (en) Bicyclic ketone compounds and methods of use thereof
SG11201902531QA (en) Liquid pharmaceutical composition
SG11201804704PA (en) Compositions and methods for decreasing tau expression
SG11201909680UA (en) Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl compounds